Is ExlService Holdings (EXLS) Undervalued After Vivek Jetley’s Exit?
ExlService Holdings (EXLS) drew investor focus after announcing that Vivek Jetley, president and head of Insurance, Healthcare and Life Sciences, will leave on 26 October 2026 to become Hexaware Technologies’ chief executive.
ExlService Holdings’ share price has been volatile over the past year, with the stock at US$37.32 after a 1 day share price return of 1.11% but down 9.44% year to date. The 1 year total shareholder return declined 15.43%, while the 5 year total shareholder return is 52.19%, suggesting near term sentiment has cooled even as longer term holders still show a gain.
Compare this leadership shake-up at ExlService Holdings with other companies where management changes could be setting up the next move by scanning our 21 high quality undiscovered gems.
With ExlService Holdings shares weaker year to date despite double digit revenue and net income growth, investors now have to weigh leadership risk against that track record. Does the current valuation still skew the risk reward toward buyers?
Most Popular Narrative: 14.2% Undervalued
At a last close of $37.32 versus a narrative fair value of $43.50, ExlService Holdings is framed as undervalued, with the story anchored in AI led growth and margin resilience.
The accelerated global adoption of AI and digital transformation in regulated industries is expanding the addressable market for ExlService, driving strong double-digit pipeline and growing annuity-like revenues; this trend supports sustained revenue growth and improved earnings visibility.
Increasing reliance by clients on advanced data and AI-driven solutions for operational efficiency positions ExlService to generate higher-margin services, benefiting both revenue mix and long-term margin expansion as traditional usage-based contracts transition to outcome-based commercial models. Read the complete narrative.
Want to see what sits behind that higher fair value? The narrative builds around faster revenue expansion, steadier earnings and a lower future earnings multiple than many peers. Curious which assumptions really carry the model?
Result: Fair Value of $43.50 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, that AI led narrative around ExlService Holdings can be knocked off course if tighter data regulations raise costs or if sector specific slowdowns hit key insurance and healthcare clients.
Find out about the key risks to this ExlService Holdings narrative.
Another View on ExlService Holdings Valuation
The fair value narrative for ExlService Holdings suggests the stock is 14.2% undervalued at $37.32 versus $43.50. However, the current P/E of 22.6x is higher than both peers at 15.1x and the US Professional Services industry at 22.4x, and above a fair ratio of 21.7x. That points to less of a clear bargain and more of a balance between potential upside and valuation risk. Which signal do you want to lean on?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Given the mixed signals around ExlService Holdings, it helps to see the full picture for yourself and move quickly while sentiment is still split. Start by reviewing the 3 key rewards.
Looking For More Investment Ideas Beyond ExlService Holdings?
If the mixed signals on ExlService Holdings have you curious about what else is out there, now can be a time to widen your watchlist with fresh ideas.
Use the Simply Wall Street Screener to quickly surface different types of opportunities that match your style, so you do not miss setups that fit you better.
- Spot potential future leaders early by scanning the 22 elite penny stocks with strong financials that already show stronger foundations than many tiny peers.
- Zero in on quality at a measured price by reviewing the 53 high quality undervalued stocks that combine fundamentals with pricing that still looks reasonable.
- Prioritise staying power and resilience by focusing on the list of solid balance sheet and fundamentals (53 results) to see companies with healthier financial footing.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com